HDFC Defence Fund, the sector's sole actively managed offering, significantly boosted its holdings in Hindustan Aeronautics (HAL) and Bhara...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

A $3 billion fund at Kotak Mahindra Asset Management Co. is backing Indian defense stocks, wagering that geopolitical tensions will boost l...

HDFC Defence Fund significantly boosted its holdings in Hindustan Aeronautics and Eicher Motors during March, adding thousands of shares to...

Gurmeet Chadha recommends SIPs in defence funds, citing strong 5–10 year growth prospects driven by rising global tensions, increased defen...

HDFC Defence Fund, India’s only active defence-focused mutual fund, raised its stake in six companies in April, including HAL, BEML, and So...

Sankarsh Chanda, CEO of Savart, discusses how the Ad Astra Fund uses AI to revolutionize fund management. By automating research and overco...

Astra said it plans to use the funds to enhance capabilities to uncover vulnerabilities in cloud environments. It also aims to deepen its f...

Elon Musk, known for pioneering innovations in technology and space exploration, has turned his attention to education with the launch of A...

AstraZeneca COVID vaccine is the same as Covishield which is used in India and several other countries.

"The EMA is absolutely correct in asking us to apply, which we have through AstraZeneca, our partners, a month ago, and that process has to...

The drug, made from a combination of two antibodies, failed its main goal to treat Covid-19 symptoms in exposed patients, AstraZeneca said ...

Alexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares per Alexion share.

The British firm said on Monday its COVID-19 vaccine was 70% effective in pivotal trials and could be up to 90% effective, giving the world...

AstraZeneca, which retains rights to the beta-blocker outside Europe, will continue to manufacture and ship product to Recordati under a su...

Earlier this week Jubilant Biosys along with US-based Endo Pharmaceuticals received an undisclosed milestone payment for their joint progra...

CRISIL has assigned ‘P1+’ rating to the short term secured fully-paid redeemable non-convertible bonus debenture issue of AstraZeneca Pharm...